# |
|
Family |
MCID |
Name |
MIFTS |
Score |
1 |
|
P
|
DBT005 |
Diabetes Insipidus |
55 |
0.249 |
|
2 |
|
c
|
HYP836 |
Hypercholesterolemia, Familial, 1 |
73 |
0.204 |
|
3 |
|
P
|
HYP750 |
Hypertriglyceridemia, Familial |
62 |
0.201 |
|
4 |
|
c
|
DNT047 |
Dentinogenesis Imperfecta Type 2 |
31 |
0.184 |
|
5 |
|
P
|
HRT032 |
Heart Disease |
75 |
0.176 |
|
6 |
|
|
BLR008 |
Bilirubin Metabolic Disorder |
57 |
0.162 |
|
7 |
|
P
|
MYP004 |
Myopathy |
70 |
0.152 |
|
8 |
|
P
|
DBT009 |
Diabetes Mellitus |
64 |
0.147 |
|
9 |
|
P
|
CRN300 |
Coronary Heart Disease 1 |
63 |
0.147 |
|
10 |
|
P
|
VSC007 |
Vascular Disease |
63 |
0.136 |
|
11 |
|
P
|
ART021 |
Arteriosclerosis |
54 |
0.136 |
|
12 |
|
P
|
KDN018 |
Kidney Disease |
72 |
0.130 |
|
13 |
|
|
ATH013 |
Atherosclerosis Susceptibility |
65 |
0.130 |
|
14 |
|
c
|
FML021 |
Familial Hypercholesterolemia |
66 |
0.118 |
|
15 |
|
P
|
MCR115 |
Microvascular Complications of Diabetes 5 |
66 |
0.111 |
|
16 |
|
|
MYT011 |
Myotonia |
34 |
0.111 |
|
17 |
|
P
|
HYP724 |
Hyperlipoproteinemia, Type Iii |
73 |
0.104 |
|
18 |
|
P
|
MYC007 |
Myocardial Infarction |
70 |
0.104 |
|
19 |
|
c
|
GLL024 |
Gallbladder Disease 1 |
53 |
0.104 |
|
20 |
|
|
48X005 |
48,xyyy |
39 |
0.104 |
|
21 |
|
|
PPL052 |
Papillomatosis, Confluent and Reticulated |
33 |
0.104 |
|
22 |
|
|
INT323 |
Intraocular Pressure Quantitative Trait Locus |
62 |
0.096 |
|
23 |
|
|
LPP008 |
Lipoprotein Quantitative Trait Locus |
62 |
0.096 |
|
24 |
|
|
LVR012 |
Liver Cirrhosis |
62 |
0.096 |
|
25 |
|
|
FTT001 |
Fatty Liver Disease |
61 |
0.096 |
|
26 |
|
|
NNT012 |
Neonatal Jaundice |
53 |
0.096 |
|
27 |
|
P
|
HYP086 |
Hypothyroidism |
69 |
0.088 |
|
28 |
|
|
LPD008 |
Lipid Metabolism Disorder |
62 |
0.088 |
|
29 |
|
P
|
NPH012 |
Nephrotic Syndrome |
60 |
0.088 |
|
30 |
|
P
|
CRD246 |
Cardiovascular System Disease |
57 |
0.088 |
|
31 |
|
|
ANG054 |
Angina Pectoris |
66 |
0.079 |
|
32 |
|
|
ISC004 |
Ischemia |
58 |
0.079 |
|
33 |
|
|
MLT161 |
Multinucleated Neurons, Anhydramnios, Renal Dysplasia, Cerebellar Hypoplasia, and Hydranencephaly |
57 |
0.079 |
|
34 |
|
P
|
NRP001 |
Neuropathy |
56 |
0.079 |
|
35 |
|
|
HYP014 |
Hyperuricemia |
52 |
0.079 |
|
36 |
|
|
XNT003 |
Xanthomatosis |
49 |
0.079 |
|
37 |
|
|
CHL004 |
Cholelithiasis |
49 |
0.079 |
|
38 |
|
P
|
KRN004 |
Kernicterus |
47 |
0.079 |
|
39 |
|
|
ADR007 |
Adrenoleukodystrophy |
75 |
0.068 |
|
40 |
|
|
PRP027 |
Peripheral Vascular Disease |
71 |
0.068 |
|
41 |
|
P
|
HYP098 |
Hypereosinophilic Syndrome |
67 |
0.068 |
|
42 |
|
P
|
PRM006 |
Primary Biliary Cirrhosis |
62 |
0.068 |
|
43 |
|
|
CHL068 |
Cholestasis |
61 |
0.068 |
|
44 |
|
P
|
FTT008 |
Fatty Liver Disease, Nonalcoholic 1 |
60 |
0.068 |
|
45 |
|
c
|
FML035 |
Familial Hyperlipidemia |
55 |
0.068 |
|
46 |
|
|
HYP060 |
Hyperinsulinism |
54 |
0.068 |
|
47 |
|
|
GLC003 |
Glucose Intolerance |
54 |
0.068 |
|
48 |
|
|
DBT010 |
Diabetic Neuropathy |
54 |
0.068 |
|
49 |
|
|
ART140 |
Arteries, Anomalies of |
52 |
0.068 |
|
50 |
|
P
|
CRC039 |
Coarctation of Aorta |
47 |
0.068 |
|
51 |
|
|
ATX019 |
Ataxia with Vitamin E Deficiency |
42 |
0.068 |
|
52 |
|
|
ADR022 |
Adrenomyeloneuropathy |
38 |
0.068 |
|
53 |
|
c
|
HNT011 |
Huntington Disease-Like 3 |
38 |
0.068 |
|
54 |
|
P
|
HPT023 |
Hepatocellular Carcinoma |
100 |
0.056 |
|
55 |
|
P
|
DBT026 |
Diabetes Mellitus, Noninsulin-Dependent |
90 |
0.056 |
|
56 |
|
P
|
OVR042 |
Ovarian Cancer |
88 |
0.056 |
|
57 |
|
P
|
PRT133 |
Proteasome-Associated Autoinflammatory Syndrome 1 |
81 |
0.056 |
|
58 |
|
c
|
LKM063 |
Leukemia, Chronic Myeloid |
72 |
0.056 |
|
59 |
|
P
|
LVR013 |
Liver Disease |
68 |
0.056 |
|
60 |
|
P
|
HPT021 |
Hepatitis |
67 |
0.056 |
|
61 |
|
|
CRB039 |
Cerebrovascular Disease |
67 |
0.056 |
|
62 |
|
|
HYP056 |
Hypoglycemia |
66 |
0.056 |
|
63 |
|
P
|
ADN016 |
Adenocarcinoma |
64 |
0.056 |
|
64 |
|
|
INT002 |
Intermittent Claudication |
61 |
0.056 |
|
65 |
|
P
|
MYL006 |
Myeloid Leukemia |
60 |
0.056 |
|
66 |
|
c
|
ACT027 |
Acute Pancreatitis |
60 |
0.056 |
|
67 |
|
c
|
ACT071 |
Acute Kidney Failure |
60 |
0.056 |
|
68 |
|
|
ADN018 |
Adenoma |
59 |
0.056 |
|
69 |
|
|
ERY003 |
Erythema Multiforme |
58 |
0.056 |
|
70 |
|
|
EYD002 |
Eye Disease |
58 |
0.056 |
|
71 |
|
P
|
GLL020 |
Gallbladder Disease |
57 |
0.056 |
|
72 |
|
P
|
ZLL001 |
Zellweger Syndrome |
57 |
0.056 |
|
73 |
|
P
|
HYP076 |
Hyperthyroidism |
55 |
0.056 |
|
74 |
|
|
IMP005 |
Impotence |
52 |
0.056 |
|
75 |
|
|
HPT014 |
Hepatorenal Syndrome |
50 |
0.056 |
|
76 |
|
|
47X002 |
47,xyy |
49 |
0.056 |
|
77 |
|
c
|
HYP555 |
Hypertriglyceridemia, Transient Infantile |
39 |
0.056 |
|
78 |
|
c
|
ECT041 |
Ectodermal Dysplasia-Syndactyly Syndrome 2 |
35 |
0.056 |
|
79 |
|
P
|
CLR023 |
Colorectal Cancer |
99 |
0.039 |
|
80 |
|
P
|
BRS047 |
Breast Cancer |
97 |
0.039 |
|
81 |
|
|
MYL069 |
Myeloma, Multiple |
85 |
0.039 |
|
82 |
|
c
|
HYP595 |
Hypertension, Essential |
84 |
0.039 |
|
83 |
|
P
|
PNC035 |
Pancreatic Cancer |
84 |
0.039 |
|
84 |
|
|
IMM167 |
Immune Deficiency Disease |
78 |
0.039 |
|
85 |
|
P
|
BDY004 |
Body Mass Index Quantitative Trait Locus 11 |
76 |
0.039 |
|
86 |
|
c
|
ATR087 |
Atrial Standstill 1 |
75 |
0.039 |
|
87 |
|
|
LPT014 |
Leptin Deficiency or Dysfunction |
74 |
0.039 |
|
88 |
|
c
|
SPN225 |
Spondyloarthropathy 1 |
73 |
0.039 |
|
89 |
|
P
|
FML018 |
Familial Mediterranean Fever |
73 |
0.039 |
|
90 |
|
|
HMN044 |
Human Immunodeficiency Virus Type 1 |
71 |
0.039 |
|
91 |
|
|
DFC004 |
Deficiency Anemia |
70 |
0.039 |
|
92 |
|
P
|
AMY004 |
Amyloidosis |
70 |
0.039 |
|
93 |
|
|
MYL009 |
Myelodysplastic Syndrome |
70 |
0.039 |
|
94 |
|
|
LGH007 |
Leigh Syndrome |
70 |
0.039 |
|
95 |
|
|
CNG034 |
Congestive Heart Failure |
69 |
0.039 |
|
96 |
|
c
|
NRD033 |
Neurodegeneration with Brain Iron Accumulation 2a |
69 |
0.039 |
|
97 |
|
P
|
ART022 |
Arthritis |
69 |
0.039 |
|
98 |
|
|
SVR097 |
Severe Cutaneous Adverse Reaction |
69 |
0.039 |
|
99 |
|
P
|
SLP006 |
Sleep Apnea |
69 |
0.039 |
|
100 |
|
P
|
PNM007 |
Pneumonia |
68 |
0.039 |
|
101 |
|
P
|
TRN020 |
Turner Syndrome |
67 |
0.039 |
|
102 |
|
c
|
MCR129 |
Microvascular Complications of Diabetes 1 |
66 |
0.039 |
|
103 |
|
P
|
ATR011 |
Atrial Fibrillation |
66 |
0.039 |
|
104 |
|
P
|
DRM053 |
Dermatitis, Atopic |
66 |
0.039 |
|
105 |
|
c
|
FML001 |
Familial Atrial Fibrillation |
65 |
0.039 |
|
106 |
|
|
TNG002 |
Tangier Disease |
65 |
0.039 |
|
107 |
|
|
YMN001 |
Yemenite Deaf-Blind Hypopigmentation Syndrome |
65 |
0.039 |
|
108 |
|
P
|
HRP006 |
Herpes Simplex |
65 |
0.039 |
|
109 |
|
|
MND021 |
Mandibular Hypoplasia, Deafness, Progeroid Features, and Lipodystrophy Syndrome |
65 |
0.039 |
|
110 |
|
|
CLN015 |
Colon Adenocarcinoma |
65 |
0.039 |
|
111 |
|
P
|
ART062 |
Arthrogryposis, Renal Dysfunction, and Cholestasis 1 |
65 |
0.039 |
|
112 |
|
|
APN008 |
Apnea, Obstructive Sleep |
64 |
0.039 |
|
113 |
|
|
BRC012 |
Brucellosis |
64 |
0.039 |
|
114 |
|
P
|
ABD014 |
Abdominal Obesity-Metabolic Syndrome 1 |
64 |
0.039 |
|
115 |
|
c
|
ATS013 |
Autosomal Recessive Congenital Ichthyosis |
63 |
0.039 |
|
116 |
|
|
KRN002 |
Kearns-Sayre Syndrome |
63 |
0.039 |
|
117 |
|
c
|
ACT068 |
Acute Cystitis |
63 |
0.039 |
|
118 |
|
c
|
ATM011 |
Autoimmune Hepatitis |
63 |
0.039 |
|
119 |
|
c
|
MTR018 |
Maturity-Onset Diabetes of the Young, Type 1 |
62 |
0.039 |
|
120 |
|
P
|
PSR002 |
Psoriasis |
62 |
0.039 |
|
121 |
|
c
|
HPT003 |
Hepatitis a |
62 |
0.039 |
|
122 |
|
c
|
BRN108 |
Branchiootic Syndrome 1 |
62 |
0.039 |
|
123 |
|
|
3HY005 |
3-Hydroxyacyl-Coa Dehydrogenase Deficiency |
62 |
0.039 |
|
124 |
|
|
ALL026 |
Allergic Hypersensitivity Disease |
62 |
0.039 |
|
125 |
|
|
CRC021 |
Carcinosarcoma |
62 |
0.039 |
|
126 |
|
|
NTR005 |
Nutritional Deficiency Disease |
62 |
0.039 |
|
127 |
|
|
NNL005 |
Non-Alcoholic Fatty Liver Disease |
61 |
0.039 |
|
128 |
|
|
HYP066 |
Hyperglycemia |
61 |
0.039 |
|
129 |
|
|
CHN055 |
Chanarin-Dorfman Syndrome |
61 |
0.039 |
|
130 |
|
|
DRM006 |
Dermatitis |
61 |
0.039 |
|
131 |
|
P
|
ENC018 |
Encephalopathy |
61 |
0.039 |
|
132 |
|
P
|
PNC044 |
Pancreatitis |
61 |
0.039 |
|
133 |
|
P
|
LPS004 |
Lupus Erythematosus |
61 |
0.039 |
|
134 |
|
|
HPT019 |
Hepatic Encephalopathy |
60 |
0.039 |
|
135 |
|
|
ACQ007 |
Acquired Immunodeficiency Syndrome |
60 |
0.039 |
|
136 |
|
P
|
BND020 |
Bone Disease |
59 |
0.039 |
|
137 |
|
|
HYD058 |
Hydrops, Lactic Acidosis, and Sideroblastic Anemia |
59 |
0.039 |
|
138 |
|
|
DBT087 |
Diabetes Insipidus, Neurohypophyseal |
58 |
0.039 |
|
139 |
|
|
GLB001 |
Gilbert Syndrome |
58 |
0.039 |
|
140 |
|
P
|
ALC033 |
Alcohol Use Disorder |
58 |
0.039 |
|
141 |
|
|
BRG013 |
Buerger Disease |
58 |
0.039 |
|
142 |
|
P
|
GLM007 |
Glomerulonephritis |
57 |
0.039 |
|
143 |
|
c
|
CHL119 |
Cholangitis, Primary Sclerosing |
57 |
0.039 |
|
144 |
|
P
|
PLY041 |
Polymyositis |
57 |
0.039 |
|
145 |
|
|
DSS009 |
Disseminated Intravascular Coagulation |
57 |
0.039 |
|
|
147 |
|
c
|
ACT075 |
Acute Myocardial Infarction |
57 |
0.039 |
|
148 |
|
|
THR024 |
Thrombosis |
57 |
0.039 |
|
149 |
|
P
|
PYL005 |
Pyelonephritis |
56 |
0.039 |
|
150 |
|
P
|
MYS005 |
Myositis |
56 |
0.039 |
|
151 |
|
P
|
MTC069 |
Mitochondrial Disorders |
56 |
0.039 |
|
152 |
|
|
NRL004 |
Neuroleptic Malignant Syndrome |
56 |
0.039 |
|
153 |
|
P
|
HYP838 |
Hyperlipidemia, Familial Combined, 3 |
56 |
0.039 |
|
154 |
|
|
AGN016 |
Aging |
56 |
0.039 |
|
155 |
|
P
|
GST044 |
Gastritis |
56 |
0.039 |
|
156 |
|
|
HYP005 |
Hypokalemia |
55 |
0.039 |
|
157 |
|
|
MCL006 |
Macular Retinal Edema |
55 |
0.039 |
|
158 |
|
P
|
DRR001 |
Diarrhea |
55 |
0.039 |
|
159 |
|
|
HMN014 |
Human Immunodeficiency Virus Infectious Disease |
55 |
0.039 |
|
160 |
|
P
|
PTT006 |
Pituitary Adenoma |
55 |
0.039 |
|
161 |
|
|
ENC067 |
Encephalopathy, Progressive, Early-Onset, with Episodic Rhabdomyolysis |
55 |
0.039 |
|
162 |
|
|
ANL018 |
Analbuminemia |
54 |
0.039 |
|
163 |
|
|
PPL022 |
Papilloma |
54 |
0.039 |
|
164 |
|
|
TRC023 |
Trichinosis |
53 |
0.039 |
|
165 |
|
P
|
HYP083 |
Hypopituitarism |
53 |
0.039 |
|
166 |
|
|
PLY118 |
Polyglucosan Body Myopathy 1 with or Without Immunodeficiency |
53 |
0.039 |
|
167 |
|
|
PRP080 |
Peripheral Artery Disease |
53 |
0.039 |
|
168 |
|
P
|
RTN018 |
Retinal Disease |
53 |
0.039 |
|
169 |
|
c
|
MCR113 |
Microvascular Complications of Diabetes 3 |
52 |
0.039 |
|
170 |
|
c
|
BDY021 |
Body Mass Index Quantitative Trait Locus 20 |
52 |
0.039 |
|
171 |
|
|
PST011 |
Pustulosis of Palm and Sole |
52 |
0.039 |
|
172 |
|
|
GLC009 |
Glucosephosphate Dehydrogenase Deficiency |
52 |
0.039 |
|
173 |
|
c
|
BDY020 |
Body Mass Index Quantitative Trait Locus 19 |
52 |
0.039 |
|
174 |
|
c
|
HYP843 |
Hypoalphalipoproteinemia, Primary, 2 |
52 |
0.039 |
|
175 |
|
|
LMY002 |
Leiomyoma |
52 |
0.039 |
|
176 |
|
|
SPN051 |
Spondylitis |
51 |
0.039 |
|
177 |
|
|
THR016 |
Thrombophlebitis |
51 |
0.039 |
|
178 |
|
|
LNG031 |
Lung Benign Neoplasm |
51 |
0.039 |
|
179 |
|
|
END086 |
End Stage Renal Disease |
51 |
0.039 |
|
180 |
|
P
|
CHL066 |
Cholangitis |
51 |
0.039 |
|
181 |
|
|
HYP081 |
Hypolipoproteinemia |
51 |
0.039 |
|
182 |
|
c
|
HNT004 |
Huntington Disease-Like 2 |
50 |
0.039 |
|
183 |
|
P
|
ESN008 |
Eosinophilic Pneumonia |
50 |
0.039 |
|
184 |
|
|
MCL027 |
Macular Dystrophy, Dominant Cystoid |
50 |
0.039 |
|
185 |
|
c
|
HYP739 |
Hyperlipoproteinemia, Type Iv |
50 |
0.039 |
|
186 |
|
|
RBF001 |
Riboflavin Deficiency |
49 |
0.039 |
|
187 |
|
P
|
MYT002 |
Myotonic Dystrophy |
49 |
0.039 |
|
188 |
|
P
|
MTC133 |
Mitochondrial Myopathy |
49 |
0.039 |
|
189 |
|
P
|
OPN001 |
Open-Angle Glaucoma |
49 |
0.039 |
|
190 |
|
|
MTC005 |
Mitochondrial Metabolism Disease |
49 |
0.039 |
|
191 |
|
|
URM002 |
Uremia |
49 |
0.039 |
|
192 |
|
|
VCC001 |
Vaccinia |
49 |
0.039 |
|
193 |
|
|
ATS010 |
Autosomal Recessive Disease |
48 |
0.039 |
|
194 |
|
P
|
SCL009 |
Sclerosing Cholangitis |
48 |
0.039 |
|
195 |
|
|
INT067 |
Interstitial Nephritis |
48 |
0.039 |
|
196 |
|
c
|
BDY005 |
Body Mass Index Quantitative Trait Locus 9 |
48 |
0.039 |
|
197 |
|
|
CRY008 |
Cryopyrin-Associated Periodic Syndrome |
47 |
0.039 |
|
198 |
|
|
THY128 |
Thyroid Tumor |
47 |
0.039 |
|
199 |
|
c
|
MCR120 |
Microvascular Complications of Diabetes 7 |
47 |
0.039 |
|
200 |
|
c
|
INH020 |
Inherited Metabolic Disorder |
47 |
0.039 |
|
201 |
|
c
|
BDY019 |
Body Mass Index Quantitative Trait Locus 18 |
47 |
0.039 |
|
202 |
|
|
LPD009 |
Lipid Storage Disease |
46 |
0.039 |
|
203 |
|
c
|
BDY010 |
Body Mass Index Quantitative Trait Locus 4 |
46 |
0.039 |
|
204 |
|
c
|
BDY015 |
Body Mass Index Quantitative Trait Locus 12 |
46 |
0.039 |
|
205 |
|
|
SQM002 |
Squamous Cell Papilloma |
46 |
0.039 |
|
206 |
|
|
PRX001 |
Peroxisomal Disease |
46 |
0.039 |
|
207 |
|
c
|
BDY017 |
Body Mass Index Quantitative Trait Locus 14 |
45 |
0.039 |
|
208 |
|
c
|
BDY011 |
Body Mass Index Quantitative Trait Locus 10 |
45 |
0.039 |
|
209 |
|
|
HPT004 |
Hepatic Coma |
45 |
0.039 |
|
210 |
|
|
FSH001 |
Fish-Eye Disease |
45 |
0.039 |
|
211 |
|
|
ORG002 |
Organic Acidemia |
44 |
0.039 |
|
212 |
|
c
|
HYP272 |
Hypercholesterolemia, Familial, 3 |
44 |
0.039 |
|
213 |
|
c
|
BDY006 |
Body Mass Index Quantitative Trait Locus 8 |
44 |
0.039 |
|
214 |
|
c
|
BDY012 |
Body Mass Index Quantitative Trait Locus 7 |
44 |
0.039 |
|
215 |
|
P
|
MYG005 |
Myoglobinuria |
44 |
0.039 |
|
216 |
|
P
|
HYP121 |
Hypoalphalipoproteinemia |
43 |
0.039 |
|
217 |
|
c
|
ICH049 |
Ichthyosis, Congenital, Autosomal Recessive 2 |
43 |
0.039 |
|
218 |
|
|
MNN017 |
Mononeuropathy |
42 |
0.039 |
|
219 |
|
c
|
BDY007 |
Body Mass Index Quantitative Trait Locus 1 |
42 |
0.039 |
|
220 |
|
|
CTS005 |
Catastrophic Antiphospholipid Syndrome |
42 |
0.039 |
|
221 |
|
c
|
SZR022 |
Seizures, Benign Familial Neonatal, 1 |
42 |
0.039 |
|
222 |
|
c
|
HYP841 |
Hypoalphalipoproteinemia, Primary, 1 |
41 |
0.039 |
|
223 |
|
|
NTR007 |
Neutral Lipid Storage Disease with Myopathy |
41 |
0.039 |
|
224 |
|
c
|
MCR130 |
Microvascular Complications of Diabetes 6 |
41 |
0.039 |
|
225 |
|
c
|
MCR133 |
Microvascular Complications of Diabetes 4 |
41 |
0.039 |
|
226 |
|
c
|
MCR112 |
Microvascular Complications of Diabetes 2 |
41 |
0.039 |
|
227 |
|
|
PYL004 |
Pyelitis |
40 |
0.039 |
|
228 |
|
|
RPD005 |
Rapidly Involuting Congenital Hemangioma |
38 |
0.039 |
|
229 |
|
|
MSC190 |
Muscular Disease |
37 |
0.039 |
|
230 |
|
|
GRN009 |
Granulomatous Hepatitis |
33 |
0.039 |
|
231 |
|
|
XLN206 |
X-Linked Intellectual Disability-Macrocephaly-Macroorchidism Syndrome |
32 |
0.039 |
|
232 |
|
|
KDN013 |
Kidney Hypertrophy |
32 |
0.039 |
|
233 |
|
|
INF009 |
Inflammatory Spondylopathy |
31 |
0.039 |
|
234 |
|
|
SPR017 |
Spermatocele |
31 |
0.039 |
|
235 |
|
|
LCH014 |
Lichen Amyloidosis |
31 |
0.039 |
|
236 |
|
|
ERY066 |
Erythema Multiforme Major |
30 |
0.039 |
|
237 |
|
c
|
BLR024 |
Biliary Cirrhosis, Primary, 1 |
30 |
0.039 |
|
238 |
|
|
ANG037 |
Angiomatosis |
28 |
0.039 |
|
239 |
|
c
|
RNG015 |
Ring Chromosome 2 |
26 |
0.039 |
|
240 |
|
|
STN013 |
Stenotrophomonas Maltophilia Infection |
25 |
0.039 |
|
241 |
|
|
PPL061 |
Papular Epidermal Nevi with Skyline Basal Cell Layers Syndrome |
25 |
0.039 |
|
242 |
|
|
URT049 |
Urate Oxidase, Pseudogene |
25 |
0.039 |
|
243 |
|
|
DPS001 |
Dipsogenic Diabetes Insipidus |
23 |
0.039 |
|
244 |
|
|
ORN004 |
Ornithinemia |
17 |
0.039 |
|